Key facts
- This page summarizes Richard Steven Morris's Form 4 filing for Passage BIO, Inc. (PASG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 May 2021, 18:09.
Richard Steven Morris - 21 May 2021 Form 4 Insider Report for Passage BIO, Inc. (PASG)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- PASG
- Reported as of
- 21 May 2021
- Net transaction value
- +$30,000
- SEC form
- 4
- Accepted by SEC
- 21 May 2021, 18:09:24 UTC
- Next SEC filing
- 09 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edgar Cale, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Richard Steven Morris filed Form 4 for Passage BIO, Inc. (PASG) on 21 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$30,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PASG
transaction
Common Stock
Purchase
- Transaction value
- $30,000
- Shares
- +2,171
- Change %
- +66%
- Price
- $13.82*
- Shares after
- 5,454
- Date
- 21 May 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Includes 2020 Employee Stock Purchase Plan allocations of 1,495 shares that occurred since the date of the reporting person's last ownership report.